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Abstract
Objective: The project aims to build a framework for conducting clinical trials for long-term inter-
planetary missions to contribute to innovation in clinical trials on Earth, especially around patient
involvement and ownership.
Methods:We conducted two workshops in which participants were immersed in the speculative
scenario of an interplanetary mission in which health problems emerged that required medical
trials to resolve. The workshops used virtual reality and live simulation to mimic a zero-gravity
environment and visual perception shifts andwere followed by group discussion.
Results: Some key aspects for the framework that emerged from the workshops included: (a)
approaches to be inclusive in themanagement of the trial, (b) approaches to be inclusive in design-
ing the research project (patient preference trials, n-of-1 trials, designing clinical trials to be
part of a future prospective meta-analysis, etc), (c) balancing the research needs and the com-
munity needs (eg, allocation of the participants based on both research and community need),
(d) ethics and partnerships (ethics and consent issues and how they relate to partnerships and
relationships).
Conclusion: In identifying some key areas that need to be incorporated in future planning of
clinical trials for interplanetary missions, we also identified areas that are relevant to engaging
patients in clinical trials on Earth. We will suggest using the same methodology to facilitate more
in-depth discussions on specific aspects of clinical trials in aerospace medicine. The methodology
can be more widely used in other areas to open new inclusive conversations around innovating
researchmethodology.
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1 INTRODUCTION
OnEarth, randomized controlled trials (RCT) are considered toprovide
the best available evidence to inform decisions on the effectiveness
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of medical treatments. These trials are usually repeated across the
world on different populations with numbers of participants ranging
in size and might be up to several thousand. This provides robust data
indicating whether effectiveness can be generalized. In aerospace
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medicine, the number of astronauts is limited so commissioning large
clinical trials is challenging, resulting in either small case studies or
simulating space conditions on Earth to provide additional numbers
and facilitate randomization. Additionally, due to the environment and
lack of gravity, there will be new questions when randomization to the
control group is detrimental to health and consequently unethical.
Future research for space exploration will not only require repeat-
ing terrestrial research in simulated/space environments, it also
requires innovative approaches to the methods of clinical research
to investigate these new challenges. Long-term missions require the
continuous commitment and motivation of participants in the clinical
trial; therefore patient involvement in the research process is more
important. In this project, we developed and piloted a new approach—
speculative theorization using simulation (including virtual reality [VR]
and live-simulation) grounded in evidence synthesis. The project used
speculative theorization to identify new methods to study complex
applied clinical research questions and engage with a more diverse
group of individuals from different disciplines and experiences. This
pilot focused on a specific research topic—conducting clinical trials for
the health of astronauts in micro, or partial, gravity. As the project
developed, we realized the speculative theorization is also a beneficial
thought experiment to encourage trialists, practitioners and members
of the public to thinkmore seriously about how to design inclusive clin-
ical trials in partnerships about patients due to the restrictive nature
of the scenario—you have to design the trial in a way that all or at least
more participants agree to participate and also consider the social and
cultural implications of the trial on the community.
The project started a few systematic reviews1-3 around specific
questions in aerospace medicine that highlighted some issues around
systematic reviews and primary studies in aerospace medicine.
The methods to synthesize evidence on a focused health research
question are well documented in the literature.4,5 However, there
are specific challenges in reviews of aerospace medicine that we
observed in previous reviews,1,2 like databases and resources to
search for studies (Table 1). The other issues are highlighted in Table 2.
Systematic reviews will use certain structure likes PICO (stands for
participants/population, intervention, comparison, outcome) to focus
the research question. In the case of systematic reviews in aerospace
medicine, the population are usually either astronauts, space tourists
or individuals participating in simulated studies attempting to replicate
a certain aspect of space missions. In the previous reviews that we
were involved, the outcome measurements that were predominately
used in the included studies (and to our knowledge in a lot of space
operations) are biomedical or physiological outcomes. We raised the
need to include patient-relevant outcomes in these trials, and it was
also a topic that came up in this project.
These issues might be a reflection of the culture of medicine in
space is predominantly top-down, that is, astronauts are required to
do all manner of medical tests and have them performed on them-
selves in order to be astronauts. The Mars scenario fundamentally
challenges the space industry culture of medical tests. However, this
proposed culture-shift to an all-inclusive test paradigm for crews also
begs questions of the culture of medical trials as they are on Earth
and the capacity to change the existing structures and frameworks.
At this stage, it is also worth mentioning a current recent incidence
related to the communication between an astronaut and his clinician.
Chris Hadfield talks in his book about how a panel of surgeons decided
on surgery for him without consulting him before his last mission
to International Space Station. He resisted the decision as there
was inadequate evidence to support it. This example demonstrates
the different values and preferences of the person involved and the
managers in situations when the evidence is uncertain.6
This study uses a methodological approach that shares traits
with speculative and critical design, using imagined scenarios, props,
imagery, and diegetic prototypes to raise questions regarding prefer-
able futures. These design methods often take inspiration from sci-
ence/speculative fiction as away to trigger debate anddiscussion.7 The
influence of art and culture (including futuristic media) may shape or
influence our vision of the future and even guide the design of med-
ical products, but currently there are few visions of future medical
research that encompasses innovation of methods of clinical research.
To build the scenario for this workshop that is both future-facing
as well as retaining and drawing from present medical knowledge, the
experience andquestions contained tropes fromboth science fiction as
well as tropes from the history of clinical trials. An example that influ-
enced the scenario built for this workshop is that of sailors affected
by scurvy on naval vessels in the 17th century, a situation that shares
resemblances to the conundrum of clinical trials in space missions.8
Popular science fiction movies can shape or influence our imagina-
tion for the future but do not engage all aspects of medical research
development. For example, the Qualcomm Tricorder X-prize has been
awarded to a family-led teamtodevelop amedical device that intended
to develop technologies to diagnose a set of 13 medical conditions
independent of health professionals or facilities and continuouslymea-
sure five vital signs in 2017. The idea was inspired by the popular sci-
ence fiction series Star Trek. In the Star Trek series and similar sci-fi
movies and series, a doctor uses complex technologies to make very
accurate diagnoses (through micro- and nanotechnologies, data and
information) and often finds a treatment to cure the problem/disease
(in lots of cases to total health without adverse events). In this and
similar popular sci-fi movies and series, the storyline emphasizes the
increasing accuracy of diagnostic technologies and the skill and genius
of the doctor. Less attention is given to the possibilities of using inno-
vative clinical trial research methods in space missions. The conun-
drumof clinical trials in spacemissions and the scenario explored in this
workshop has a lot of similarities to the historical scenario of sailors
affected by scurvy on navy ships in the 17th century. The standard
method of proposing medical treatments (skillful and smart doctors,
suggesting treatments based on experience) generated several possi-
ble treatments for scurvy. However, therewere still uncertainties as to
which treatmentswork best to treat scurvy. Themortality andmorbid-
ity of scurvy between sailorswere still high. James Lindwas anavydoc-
tor who trawled the literature and anecdotal advice on treatments and
then conducted a small controlled clinical trial to identify an effective
treatment. The latter provided evidence to combat the existing conflict
and uncertainty.8
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TABLE 1 Space research specific databases
Electronic database Description
Space Life Sciences NLM subset https://www.nlm.nih.gov/databases/databases_space.html
This is a subset of the USNational Library ofMedicine.
NASA Scientific and Technical
Information (STI) Program
https://www.sti.nasa.gov/
This is a database of citations, documents and images created or funded by
NASA or its predecessor NACA. It is searchable via the Technical Reports
Server (NTRS): https://ntrs.nasa.gov/advSearch.jsp
PubSpace https://www.nasa.gov/open/researchaccess/pubspace
This is an archive of NASA-funded research publications which aremade
available to the public via the PubMed Central platform.
ESA—Erasmus Experiment Archive
(EEA)
http://eea.spaceflight.esa.int/portal/
This is an archive of ESA-funded research experiments, independent of any
subsequent publication as journal articles.
NASA—Life Science Data Archive
(LSDA)
https://lsda.jsc.nasa.gov/
This is an archive of the biomedical experiments conducted by NASA including
the Human Research Program.
DLR—German Aerospace Centre http://elib.dlr.de/cgi/search/advanced
This is an online collection of conference abstracts, reports and citations of
some published journal articles. There is no explicit collection policy.
Canadian Space Agency Canadian space agency does not seem to have a database associated with their
work. They have a publication section that includes audits and reports and they
have an open access data portal
http://www.asc-csa.gc.ca/eng/open-data/access-the-data.asp#life-sciences.
The open data portal at themoment has only one type of life sciences data –
performance readiness evaluation and training tool.
International Space University The library of the university has its own database and provides advanced search
option available. However, it is unclear what the process of selecting, archiving
and indexing of the resources in the database https://isulibrary.isunet.edu/
British Antarctic Survey Wewill expect that some reviewsmight include Antarctic missions as a simulated
environment. The British Antarctic Survey has ameta-data section including
human factors although currently has zero entries https://data.bas.ac.uk/
Other online sources
Austrian Space Forums
(ÖsterreichischesWeltraum
Forum)
They conduct planetary analogmission research and if that type of simulation
studies are included in the review, it is helpful to check the website
https://oewf.org/
British Interplanetary Society (BIS) The Society produces two journals that can include research publications that will
not be picked up in other databases that we search in systematic reviews
https://www.bis-space.com/what-we-do/publications
NASA evidence book NASA human research program is a collection of evidence based risk reports.
Unfortunately, there is not enough detail on themethods of these evidence
books available to judge their quality. However, they can be a resource to
identify research based onwhat they have cited or use in the documentation
https://humanresearchroadmap.nasa.gov/evidence/
The Japanese Aerospace
Exploration Agency (JAXA)
The agency does not seem to be have a database for identification of articles but
has a list of experiments that they are involved in—this includes ones around
medical experimentation. http://iss.jaxa.jp/en/kiboexp/
A list of conferences andmeetings with relevant research abstracts
▪ Aerospacemedicine associated (ASMS) Annual Conference
▪ International Astronautical Congress
▪ European LowGravity Research Association Conference
▪ World ExtremeMedicine Conference
▪ UK Space Environments Conference
▪ Astrobiology Society of Britain Conference
▪ The International Congress of Aviation and SpaceMedicine (ICASM)
▪ International Conference on Astrobiology (AstroBioCon)
▪ Annual International Space Station R&DConference
There is a need to reconceptualize clinical trials in interplane-
tary space missions because of how potentially different conditions
would be between living on Earth and settling on other planets, for
example, Mars. These include physical aspects such as partial grav-
ity or a different atmosphere, along with the psychological and social
issues of small and isolated populations. This small and isolated com-
munity can be simulated with smaller numbers of humans; however,
there are other challenges about the relationship between individu-
als, patients, clinicians, and trials that introduce new problems. More-
over, risks associated with the decisions and their consequences have
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TABLE 2 Methodological gaps from previous systematic reviews
Systematic review Methodological gaps
Winnard A 20171 Lack of consistency in reporting outcomesmeasures and the focus on biomedical measurements instead of
patient relevant ones
All studies were indirect simulation studies with heterogeneous context and delivery of intervention that
introduced challenged both in synthesizing the evidence or judging its applicability and generalizability
Currently, high-quality studies done on astronaut are not available. Due to small number of astronauts in
eachmission, the studies are usually not in the form of clinical trials
Richter C 20172 It has similar gaps to the previous one. In addition to this, the issue of finding the threshold for gravity that has
the least problematic impact on the human bodywhich requires regression analysis and exposure of
different types of gravities.
In relation to this project, we can translate the issue of changes in gravity on the human body to get toMars;
from earth gravity tomicrogravity and then the partial gravity onMars.
different implications in space that can affect the decision-making
process.
2 METHODS
We designed a creative workshop that included a simulation of a
disaster during a space mission, the usage of optical design to distort
vision and an interactive methodological discussion. The workshop
was based on the topics identified from previous systematic reviews
(Table 2) and the speculative theorization around clinical trials in
space missions. It intended to create altered states such as a different
weight and different perspective to jolt participants into imagining the
realities of astronauts.
The workshop was shaped around a speculative scenario (Table 3).
The first workshop was run in Torbay and South Devon NHS Founda-
tionTrust and the secondone at theCochraneColloquium (Edinburgh).
The immersive part built on previous research on eliciting audience
participation by providing a restrictive environment like a space mis-
sion rather than relying solely on pictorial realism. It included a virtual
reality demonstration of a Soyuz spaceship leaving Earth followed by
a live simulation of a spaceship accident. The latter was not intended
to be realistic; it attempted to demonstrate some limiting aspects of a
space mission. It included an individual in a fat suit, tinted glasses, and
big gloves who was supported by suspension bands and could move
around (the video is available via contacting withMonaNasser). A sec-
ond individual was present who was immobile and noncommunicative
and dressed in a Biohazard decontamination suit. The room had lim-
ited lighting. There were some people in the room and some outside
the roomwatching throughamonitor (themission control). Therewere
clear problems with communications, and only certain people could
talk. The simulation was of a post-accident scenario where an astro-
naut had to attempt to rescue an injured colleaguewhilst the responsi-
ble clinicianswere based inmission control. Due to damage to the com-
munication equipment, the remainder of the crew could only receive
and pass information via mission control (simulated by the team in the
sim suite control room) and direct their colleague. During the debrief-
ing, the participants discussed the challenges of dealing with the limi-
tations of the situations. They usually started to follow their standard
emergencymedical procedures. They did not consider that itmight not
apply to the unusual situation, for example, they first attempted to take
the pulse through the artery—which was not possible when wearing
the Biohazard “space” suit.
As the speculative scenario concerned an unexpected eye problem,
we wanted to encourage the participants to think beyond the usual
eye problems and expect unusual health/disease consequences. In any
new context like Mars (or even certain situations on earth like out-
break of a new disease or monitoring adverse events of a new drug),
you need to monitor for unexpected health/disease consequences. To
achieve this, we provided the participants with the opportunity to
use optical devices developed by Terry Pope (the hyperscope and the
pseudoscope) which, through repositioning the eyes, simulate the pos-
sible perceptual changes which impact vision.9 Please note it is not
suggested that repositioning the eye is the consequence of long-term
exposure to partial or microgravity; it was used as an example of an
unexpected vision problem to demonstrate that new positive or neg-
ative health/disease consequences sometimes require a new and unfa-
miliar way for both the patients and clinicians to describe the problem
and communicate the issues.
The immersivepartwas followedbyan interactivediscussionwhere
participants worked through the eye problem scenario. Participants
were asked to draw diagrams to demonstrate how they would struc-
ture the clinical research in this environment and how the different
stakeholders and sections engage in different steps.
The second workshop did not include the immersive section and
only included the speculative scenario of the eye problem and the
interactive methodological diseases. The highly constrained scenario
brought into sharp focus the importance of patient/consumer involve-
ment in the design and conduct of research, the importance of
informed consent and the challenges of maintaining equipoise.
The workshop participants included trialists, clinicians, patients,
psychologists and individuals with art and humanity background.
3 RESULTS
The issues and concepts identified as part of theworkshops can be cat-
egorized as follows: (a) approaches to be inclusive in the management
of the trial; (b) approaches to be inclusive in designing the research
project (patient preference trials, N-of-1 trials, designing clinical
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TABLE 3 Mars case scenario given to participants of the workshops
Item Explanation
Case scenario In amission toMars, there are 40-50 people who are staying on that planet for three years. You have increasing
reports of individuals having differing eye problems, eg, blurriness, seeing spots, problems in seeing distance,
etc. These eye problems are affecting the ability of individuals to perform their duties and affecting the
mission in general. Moreover, it causes anxiety and stress as other members of themission are worried that
theymight become affected. You need to come upwith a solution tomanage the situation and determine
how to conduct clinical research that not only supports this mission but future ones.
Note: The scenario is based on recent reports that some astronauts experience vision impairment that can
last for a long time during and after spacemissions. The participants received quotes from astronauts that
was available in publicly available documents, eg, a quote from astronautMike Baratt—“It’s my right eye that
has apparently been permanently remodeled.”
(Ref: NASA. Vision Impairment and Intracranial Pressure [VIIP]—05.02.18.) Available at:
https://www.nasa.gov/mission_pages/station/research/experiments/1038.html.2018 and Silverman L.
Doctor Launches VisionQuest ToHelp Astronauts’ Eyeballs. Available at. https://www.npr.org/sections/
health-shots/2017/03/04/518214299/doctor-launches-vision-quest-to-help-astronauts-eyeballs?t=153618
2114599. National Public Radio; 2017.
Discussion guide for
workshop participants
How do individuals come upwith potential interventions and prioritize those that could be used in clinical
trials?Who do they involve in the decision-making process?
How do theymake decisions about what data to collect in order to evaluate the effectiveness of the
interventions? Encourage people to think about clinical outcomes, biochemical and pathological outcomes
alongwith performance outcomes. The latter is important for themission, the former important for future
missions.
If people are familiar with clinical trial methodology, encourage them to think about ideas on how theywould
change the allocation, blinding or other aspects of the clinical trial.
It will be helpful to encourage people to think and discuss ownership of clinical trials and the relationship of
individuals in themission with the leaders of themission and how it can affect selection and allocation of
individuals in the group as well as the overall social dynamic of themission.
trials to be part of a future prospective meta-analysis, identifying
biomedical, clinical, patient-related along be the performance-related
outcome, data collection over time and monitoring need for adapta-
tion and change); (c) balancing the research needs and the community
needs (allocation of the participants based on both research and
community need, for example, stratification not only based on charac-
teristics but also by roles and job specification, using adaptive design
to allocate individuals into groups and patient preferred trials); and (d)
ethics and partnerships (ethics and consent issues and how they relate
to partnerships and relationships).
3.1 Approaches to be inclusive in themanagement
of the trial
Astronauts have a lot of experience in conducting experiments as part
of a daily routine in space missions, so we expect that being part of a
clinical trial will be easier for them than standard patients. However,
we do not know how human behavior changes or adapts on long-term
missions and we expect that it will be more difficult—the isolation and
separation from family and the different selection and training criteria,
different cultures (both organizational cultures and country and eth-
nic culture) across space agencies. Therefore, it becomes more impor-
tant to have a more collaborative approach in selecting the research
questions that become the priorities for investigation in clinical tri-
als on such missions. The workshop participants raised the issue that
individuals view on the importance of outcomes changes as the health
problem progresses over time. There is currently limited research on
how these changes in priorities affect the view of the individuals on
the effects of the intervention and how it would change the results if
it is considered. We will explore this aspect in future workshops, and
long-termAntarctica orPlanetaryAnalogmissions (currently these are
mostlyMars and Lunar analogmissions) are a potential environment to
pilot and evaluate such strategies.
Therewere different approaches suggested to deal with these deci-
sions around the selection and allocation of participants to the groups:
(a) inclusive approach (somepeopleuse the termdemocratic approach)
to rank the interventions—this could be either involving everyone or
involving those who are affected in deciding which intervention has
the highest potential and aremost promising for addressing the health
care problem; (b) approaching themanager of themission or the leader
that people listen to; and (c) build a committee of key individuals to
make the decision.
The process not only depends on individual needs and values but
also the expectations and prior agreements from the mission. The
social and political impact of the clinical trial on the community was
also discussed. These impactsmight influence individuals’ involvement
in the research project and even the design of it. For example, cer-
tain expected adverse events from the treatment or consequences of
the disease might lead people to prioritize specific interventions. The
emergence of these effects can also influence the compliance of indi-
viduals throughout the trial.
3.2 Approaches to be inclusive in designing the
research project
One of the biggest challenges of aerospace medicine research is the
low sample size as the number of astronauts is limited. This, unfortu-
nately, is also often the case with simulation studies. Due to the tech-
nical requirements and costs, the number of individuals that can be
recruited in space mission clinical trials is limited. Systematic reviews
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with meta-analyses have been used to synthesize the data across clin-
ical trials, and these can increase the power and generalizability of
results. There is a possibility to address this issue using prospective
meta-analysis,which requires the spaceagencies toplan the clinical tri-
als, keeping in mind the future meta-analysis in which the clinical trial
will be included. In this way, they could also plan those clinical trials
over several space missions, especially as a health issue will probably
come up repeatedly in futuremissions with new individuals.10
During the discussion around the speculative scenario, the question
was raised whether this scenario challenges the notion that the stan-
dard RCT is the most appropriate methodology. The ethical challenges
might favor alternatives such as N-of-1 or a stepped wedge. Regard-
ing the aforementioned eye problem, in some cases, we might not be
able to treat the problem and might need to find ways to ensure that
the individuals manage symptoms to be able to perform their duties or
live their lives. In these cases and these types of treatment, N-of-1 tri-
als can be useful, so will be helpful if individuals have access to ways to
incorporate these trials in their daily life.11
Given the small number of participants, difficulty to maintain
equipoise and the ethics of the same population being involved, par-
ticipants might favor an alternative. However, this issue was not raised
in any of our workshops. In future workshops, we will explore whether
the latter is a consequence of how theworkshopwas structured or the
issuemay not be considered relevant by the participants attending our
workshop.
In both workshops, people raised the issue that not only would clin-
ical and biomedical outcomes need to be collected, but also patient-
related outcomes and performance-related ones (what people care
about). Therewas also adiscussiononunexpectedoutcomes, for exam-
ple, unexpected side effects and the need to record and identify them.
Some even suggested that wewould collect data on eachmember’s log
(which does raise ethical and consent issues).
During the workshops, people raised concerns about a set of pre-
defined and fixed outcomes at the beginning of the clinical trial. This
is important to provide relevant comparison; however, people’s priori-
ties onwhat themost important outcomes aremight change over time.
Therefore, it has been suggested that the clinical trial teamshould have
a continuous discussion with individuals in the group to see how the
outcomes evolve.
3.3 Balancing the research needs and the
community needs
Clinical trials usually involve randomization in different treatment
groups.We sometimes stratify individuals in the groups basedonother
confounders to explore their impact on the effectiveness of the inter-
vention. During the workshops, the issue was raised that each person
has a critical role in the mission. It’s vital that if the performance of
the individual is negatively affected by the trial (either that the inter-
vention does not work or the intervention has side effects), that peo-
ple with similar roles and job specification would not be in the same
treatment group. Another reason for not having people with simi-
lar roles or similar living or working places to be in the same group
is the possibility of contamination between groups. In these situa-
tions, one could implement stratified randomization to separate them
by allocating them to groups. Moreover, the investigator could use
weighted/unequal randomization which is still randomized but results
in fewer participants allocated to the experimental group (or nonex-
perimental groupwhichever is deemed to have adverse consequences)
(adaptive design).11,12 There are alternativemethods for designing the
clinical trial which can be used, such as patient-preferred clinical trials,
or different approaches to randomizing people to the groups, such as
adaptive design clinical trials.
3.4 Ethics and partnerships
The importance of partnerships and transparency was raised. It is
vital to maintain the partnership and relations with the participants
throughout the clinical trial. The workshop participants also raised the
importance of implementing the results of the trial in the same pop-
ulation, and people need to see the benefit of doing a clinical trial
to take ownership of it. In Edinburgh, we asked people how the dis-
cussion affected their views on conducting clinical trials on Earth,
and this was one of the key aspects that they highlighted. The reality
that the trial participants are also the trialists’ community, colleagues
and the patients made the participants of the workshop re-think how
they would approach designing clinical trials. This is interesting con-
sidering the ethics of conducting clinical trials in developing coun-
tries, for example, outsourcing the commercial clinical trials to Latin
America.13
Similar to the issue raised around Chris had field dilemma in the
background;6 the question was raised in the workshop, whether we
require a different ethical paradigm for this type of research. Some
questions raised were whether these interplanetary trial workshops
impose decision-making from outside, or do they encourage meth-
ods for democratic decisions, where does it leave individual decision-
making.
There was much discussion on challenges of randomizing people
to one treatment group and one control/placebo group, especially if
the intervention is codesigned with the participants and there is a
level of anxiety over eyesight loss or adverse effects from the treat-
ments. Some argued that people who sign up to such missions would
be expected to have agreed to these types of experiments. However,
social interaction, especially in difficult, complicated and stressful situ-
ations (losing eyesight can cause anxiety and stress), evolves in unpre-
dictable ways, and it is important to consider how that affects people.
Others suggested that if individuals are involved in designing the clin-
ical trial and selection of intervention, they are more likely to accept
the failure and adverse events. There were suggestions on the need to
design appropriate placebos for such clinical trials.
4 DISCUSSION
Although aspects of the experiment could have been predominately
explored in a logical and narrative way, there are other social and
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behavioral issues that require the participation of a wider audience
to identify and unpick. The combination of simulation, optical devices
andmethodological discussions provided ahelpful approach to achieve
this.
Participants of theworkshops found the interaction useful, not only
to come upwith new approaches to design clinical trials for interplane-
tarymissions but also to reconceptualize clinical trials onEarth. For the
participants, there was a realization that their evolving understand-
ing of a new physical environment can lead to new ways to approach
conduct clinical trials. In the first workshop, we explored the issue of
challenging communication between the individuals in the spacecraft
andmission control/support. However, we did not explore howmission
control could help in the eyeproblemscenario in-depth. In someanalog
Marsmissions, themission supportmight have abetter overviewof the
patterns of what happenings than clinicians involved. Although we pri-
marily designed the workshop to understand how clinical trials might
need to be changed for interplanetary missions, the workshop seems
to be a very good training tool to engage a diverse group of individuals
in the complexity of clinical trials and discussions on how to innovate
themethods of clinical trials.
The current global pandemic outbreak of coronavirus raises ques-
tions, not only about how we manage the situation, but also about
how we develop an infrastructure to collect data in a more system-
atic way to inform future decision making. Currently, many countries
have chosen social distancing as an intervention to reduce the speed of
the spread of the infection. However, good quality data will be key to
understanding whether the long term benefits of the intervention out-
weigh its social and economic consequences. This project can be used
to train individuals to find new processes and methods for unprece-
dented situations, such as disasters and pandemics.
5 CONCLUSION
This methodology provides a useful approach to re-think the research
methods to address a new challenge and problem and engage a wider
range of individuals in those discussions. The main areas for discus-
sion on innovation in this specific area (clinical trials in space mis-
sions) are: (a) approaches to be inclusive in the management of the
trial (being inclusive in the management process); (b) approaches to
be inclusive in designing the research project (patient preference
trials, N-of-1 trials, designing clinical trials to be part of a future
prospective meta-analysis, identifying biomedical, clinical, patient-
related along be the performance-related outcome, data collection
over time, and monitoring need for adaptation and change); (c) bal-
ancing the research needs and the community needs (allocation of the
participants based on both research and community need, for exam-
ple, stratification not only based on characteristics but also by roles
and job specification, using adaptive design to allocate individuals into
groups and patient preferred trials); and (d) ethics and partnerships
(ethics and consent issues and how they relate to partnerships and
relationships).
Speculative theorization using simulation and visualization
grounded in evidence synthesis can be used for other methodological
questions in aerospace medicine and wider health care research.
For this specific topic, we intend to conduct additional workshops
focusing on certain aspects of a clinical trial with a more diverse range
of scenarios that include other types of health problems, for example,
contagious ones or datasets that reflect the issues identified in this
exercise.
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